Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DB9O4X
|
|||
| Drug Name |
CYTO-402
|
|||
| Indication | Hepatocellular carcinoma [ICD-11: 2C12.02; ICD-10: C22.0; ICD-9: 155] | Phase 1 | [1] | |
| Company |
Cytocom
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Cytocom | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.